C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2011
11/10/2011	WO2011139414A2 Dexlansoprazole polymorphic forms
11/10/2011	WO2011139107A2 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
11/10/2011	WO2011138916A1 Polycyclic compound
11/10/2011	WO2011138751A2 Heterocyclic derivatives as alk inhibitors
11/10/2011	WO2011138657A1 Aryl substituted olefinic compounds as pde10a inhibitors
11/10/2011	WO2011071314A3 Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms
11/10/2011	WO2010143169A3 Compounds useful for treating aids
11/10/2011	WO2010093706A3 Chemically programmed vaccination
11/10/2011	US20110275824 Process for the manufacture of dabigatran etexilate
11/10/2011	US20110275823 Phenylimidazole compounds
11/10/2011	US20110275819 Organic compounds and their uses
11/10/2011	US20110275815 Benzylpiperazine derivatives as motilin receptor antagonists
11/10/2011	US20110275814 Material for organic electroluminescence device and organic electroluminescence device
11/10/2011	US20110275811 Heterocyclic compounds and their uses
11/10/2011	US20110275810 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
11/10/2011	US20110275803 Process for synthesizing oxidized lactam compounds
11/10/2011	US20110275800 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
11/10/2011	US20110275797 N-acyl anthranilic acid derivative or salt thereof
11/10/2011	US20110275677 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
11/10/2011	US20110275676 Triazole-substituted anthranilamides as pesticides
11/10/2011	US20110275675 Antimicrobial Dental Materials
11/10/2011	US20110275674 Small Molecules Modulator of Epigenetic Regulation and Their Therapeutic Applications
11/10/2011	US20110275673 Inhibitors of sphingosine kinase 1
11/10/2011	US20110275671 Dihydroindolinone derivatives
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275657 Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
11/10/2011	US20110275645 Small Molecules for Inhibition of Protein Kinases
11/10/2011	US20110275643 Aroylquinoline compounds
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275633 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
11/10/2011	US20110275630 Isoindolinone kinase inhibitors
11/10/2011	US20110275625 Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275624 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
11/10/2011	US20110275622 Bi-functional quinoline analogs
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275612 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275608 Piperidine-containing compounds and use thereof
11/10/2011	US20110275607 Nuclear transport modulators and uses thereof
11/10/2011	US20110275075 Sox modulators in the treatment of alopecia
11/10/2011	US20110274655 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	US20110274654 Triazoles as inhibitors of fatty acid synthase
11/10/2011	US20110274648 Hepatitis C Virus Inhibitors
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/10/2011	US20110272681 Light-emitting element material and light-emitting element
11/10/2011	US20110272679 Compound having triazole ring structure to which pyridyl group is bonded, and organic electroluminescent device
11/10/2011	CA2800998A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
11/09/2011	EP2385048A1 Hepatitis C virus inhibitors
11/09/2011	EP2385047A1 Piperidinyl-substituted isoquinolone derivatives
11/09/2011	EP2385046A1 Precursor phase and use thereof for preparing the magnesium salt tetrahydrate of an omeprazole enantiomer
11/09/2011	EP2385042A1 Prokineticin 1 receptor antagonists
11/09/2011	EP2385041A1 Pyrazole-amine compounds useful as kinase inhibitors
11/09/2011	EP2385040A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2385035A1 Preparation method of dihydroindene amide compounds their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor
11/09/2011	EP2384768A1 Phenylpropionamide compounds and the use thereof
11/09/2011	EP2384320A2 Pyrrolidine compounds which modulate the cb2 receptor
11/09/2011	EP2384318A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
11/09/2011	EP2197853B1 Insecticidal pyrimidinyl aryl hydrazones
11/09/2011	EP2139881B1 Quinolines and their therapeutic use
11/09/2011	EP1789390B1 Pyridyl inhibitors of hedgehog signalling
11/09/2011	EP1673085B1 C-met modulators and methods of use
11/09/2011	EP1633740B1 5-(acylamino)indazole derivatives as kinase inhibitors
11/09/2011	EP1007513B1 Pesticidal 1-aryl-3-iminopyrazoles
11/09/2011	CN1882542B 2-pyridone derivatives as neutrophil elastase inhibitors and their use
11/09/2011	CN1845920B 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
11/09/2011	CN102239161A 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent component
11/09/2011	CN102239160A Substituted (pyridyl)-azinylamine derivatives as fungicides
11/09/2011	CN102239159A 7-piperidinoalkyl-3,4-dihydroquinolone derivative
11/09/2011	CN102239158A Method for preparing a spiroindoline and a precursor thereof
11/09/2011	CN102239147A Quinolone compound and pharmaceutical composition
11/09/2011	CN102239146A Novel compounds as calcium channel blockers
11/09/2011	CN102238951A Pharmaceutical agent comprising quinolone compound
11/09/2011	CN102234270A Diarylurea derivatives and treatment application thereof
11/09/2011	CN102234265A Lansoprazole compound
11/09/2011	CN102234264A Synthesis method of N-[6-(8-benzyloxy quinolyl)-hexyl]carbazole
11/09/2011	CN102234263A Method for preparing anti-tumor medicine imatinib
11/09/2011	CN101638385B Novel carbostyril derivative and preparation and application thereof
11/09/2011	CN101405275B Triazolone derivative
11/09/2011	CN101343251B Thrombopoietin mimetics
11/08/2011	US8053580 Salts of benzimidazole derivative with amines and process for manufacturing the same
11/08/2011	US8053574 Organic compounds
11/08/2011	US8053463 e.g. {3-butoxy-5-[4-(4-trifluoromethoxy-phenoxy)-benzenesulfonyl]-phenyl}-acetic acid; peroxisome proliferator activated receptor modulator; antidiabetic agent; obesity, hyperlipidemia, dyslipidemia, hypertriglyceridemia, Syndrome X, insulin resistance, diabetic neuropathy, atherosclerosis, eczema
11/08/2011	US8053457 3-imidazolyl-indoles for the treatment of proliferative diseases
11/08/2011	US8053450 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/08/2011	US8053446 Cyanoguanidine compounds
11/08/2011	US8053445 Utilities of olefin derivatives
11/08/2011	US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011	CA2618393C Bis-aryl amide compounds and methods of use
11/08/2011	CA2529126C Azetidine compounds
11/08/2011	CA2509982C N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
11/08/2011	CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011	CA2476054C Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011	CA2405408C Pyrazole compounds
11/03/2011	WO2011137088A1 Herbicidal uracils
11/03/2011	WO2011136484A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011	WO2011136318A1 Therapeutic agent and preventative agent for alzheimer's disease
11/03/2011	WO2011136308A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs

1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 1080